Stock Upgrades Today Signal Strong Buy Opportunities Ahead

 TopRated
 
  TopRated
 
Follow  Message
 
 
 
TopRatedStocks uncovering top-rated companies. Providing quick insights and recommendations, they help investors discover high-potential stocks based on robust metrics.
 

•  19 Sep 2025
 

•   BSX  
   
  0.00%
•   CVS  
   
  0.00%
•   ESNT  
   
  0.00%
•   FDX  
   
  0.00%
•   HLNE  
   
  0.00%

$BSX Boston Scientific received multiple positive analyst actions today, with Oppenheimer upgrading the stock from Perform to Outperform while raising their price target. Needham also reiterated their Buy rating ahead of the company's investor day. The timing of these upgrades suggests analysts see underlying value in the company's cardiovascular and medical device portfolio.

$CVS Health stepped up to bolster its Oak Street operations as cost pressures mount across the healthcare sector. The pharmacy giant trimmed its outlook due to rising medical costs at Oak Street, but new leadership initiatives and technology upgrades are positioning the company for steady growth ahead.

$ESNT Essent Group received an upgrade to Hold as interest rates begin their anticipated decline cycle. As mortgage activity typically increases when rates fall, Essent's position in the mortgage insurance market becomes more attractive to analysts who previously held more cautious views.

$FDX FedEx emerged as one of Friday's big movers, with volume significantly above average at 7.94M versus typical 1.88M, institutional interest appears to be building around FedEx's operational efficiency improvements and market positioning.

$HLNE Goldman Sachs upgraded Hamilton Lane from Sell to Neutral, marking a significant shift in sentiment toward the alternative investment management firm. The upgrade suggests Goldman's analysts now view the private equity and credit markets specialist as fairly valued rather than overextended, potentially setting up for future positive momentum.

$HTGC Hercules Capital received a credit rating upgrade to Baa2 from Moody's with a stable outlook, citing strong performance, low leverage, and solid asset quality. The business development company benefits from improved credit metrics that should reduce funding costs and enhance dividend sustainability for income-focused investors.

$KVYO Klaviyo rating upgrade at Morgan Stanley. The email marketing and customer data platform company has seen significant institutional interest with volume reaching 3.86M compared to its average 2.34M. The upgrade reflects growing confidence in Klaviyo's market position within the competitive marketing automation space.

$MASI Masimo received an upgrade to Strong Buy from Zacks, reflecting growing optimism about the medical technology company's earnings prospects. Despite trading down 1.80% at $140.43, the upgrade suggests analysts see near-term catalysts that could drive the stock higher. The company's patient monitoring and hospital automation solutions continue to gain market traction.

$MDB MongoDB outlined ambitious growth targets at its New York conference, projecting high-teens revenue growth over the next three to five years. Needham analyst Mike Cikos maintained a Buy rating while raising the price target from $325 to $365. MongoDB focus on emerging technologies beyond its core database business has caught investor attention.

$SCI Service Corporation International received multiple upgrade mentions to Buy, with analysts citing growing optimism about earnings prospects. SCI attracts value-oriented analysts who see demographic trends supporting long-term revenue stability and potential market share expansion opportunities.

$SLDE Keefe Bruyette & Woods upgraded Slide Insurance Holdings from Market Perform to Outperform. SLDE saw exceptional volume of 5.14M compared to its typical 1.02M average. The upgrade suggests analysts see improved underwriting conditions or operational improvements that weren't previously reflected in the stock price.

$TSLA Tesla received multiple upgrade mentions throughout the day, with Baird providing a notable upgrade following the company's ambitious product target announcements. Tesla continues to generate significant institutional interest. Analysts increasingly view the electric vehicle maker as an artificial intelligence play rather than just an automotive company.

$UBER Uber gained attention as American Express announced significant upgrades to its Platinum cards, including enhanced Uber One membership benefits. Uber benefiting from increased corporate partnerships that expand its user base and transaction volume potential.

$UHS Universal Health Services received an upgrade to Buy, with analysts expressing growing optimism about the hospital operator's earnings prospects. UHS benefits from improved patient volumes and operational efficiency gains across its hospital network.

$WAY JMP Securities initiated coverage of Waystar Holding with a Market Outperform recommendation. WAY attracted significant volume of 20.10M shares compared to its 2.35M average. The initiation suggests institutional recognition of Waystar's position in healthcare payment processing technology.

$ZBH Rothschild & Co initiated coverage of Zimmer Biomet Holdings with a Buy recommendation. ZBH continues to attract analyst interest despite modest daily performance. The medical device sector remains attractive to analysts seeking exposure to demographic trends and technological innovation.

View All Headlines